UroToday1d
Clarity enters a Clinical Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Reno, Nevada (UroToday.com) Clarity Pharmaceuticals (ASX: CU6) (“Clarity”, “the Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve ...
UroToday4d
Location-based Radiology Report-Guided Semi-supervised Learning for Prostate Cancer Detection.
Prostate cancer is one of the most prevalent malignancies in the world. While deep learning has potential to further improve computer-aided prostate cancer detection on MRI, its efficacy hinges on the ...
UroToday4d
If Not Now, Then When? The Need for New Evidence in the Robotic Management of Upper Tract Urothelial Carcinoma - Beyond the Abstract
The current manuscript presented an overview of the existing challenges in robotic nephroureterectomy (RNU) for the treatment of upper tract urothelial carcinoma (UTUC) and outlined a multicentric ...
UroToday5d
A new surgical technique of robotic-assisted laparoscopic nephroureterectomy without re-docking in a single position: a single center experience.
A nephroureterectomy conventionally consists of two independent section, which will considerably prolong the operation time. We developed a novel surgical technique for robotic-assisted laparoscopic ...
UroToday4d
Prostate cancer survivorship of Australian men living with prostate cancer: Patient support programs in Australia.
Treatment for prostate cancer (PC) is associated with adverse effects, especially in patients receiving androgen deprivation therapy (ADT). The Australian Government, non-governmental organisations ...
UroToday4d
Unusual Prostate-Specific Membrane Antigen (PSMA) Splenic Uptake in a Patient With Prostate Cancer.
There are many benefits to early detection of prostate cancer, including improved survival rates, less invasive treatment options, and better quality of life. Apart from traditional tests and imaging ...
UroToday4d
Treatment Preferences and Tradeoffs Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma - Expert Commentary
With the expanding therapeutic options for patients with locally advanced or metastatic urothelial carcinoma (mUC), selecting the most appropriate option for each patient has become increasingly ...
UroToday5d
Follow Up Care After Penile Sparing Surgery for Penile Cancer: Current Perspectives.
Penile cancer (PeCa) is a rare urologic tumor worldwide. In 2024, 2100 new cases and 500 deaths are estimated in the United States. Radical surgery via total penectomy has historically been the ...
UroToday5d
A Nomogram for Predicting Infertility Risk in Patients With Varicocele Using Inflammatory Markers.
The purpose of this study was to develop a nomogram using hemogram inflammatory markers to predict the risk of infertility in patients with varicocele (VC). Patients with VC from March 2022 to June ...
UroToday4d
Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumors.
Renal parenchymal volume loss from standard partial nephrectomy (SPN) is a significant prognosticator for postoperative renal function. Tumor enucleation (TE) minimizes parenchymal loss compared to ...
UroToday4d
Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation.
While renal cell carcinoma (RCC) is often linked to smoking, obesity, and hypertension, hereditary forms also account for about 3% of RCC cases. Notably, NCCN guidelines identify 7 major hereditary ...
UroToday5d
Development of a Bladder Injury Classification System for Endoscopic Procedures: A Mixed-methods Study Involving Expert Consensus and Validation.
The widespread adoption and rapid integration of new technologies and techniques in endoscopic and laser bladder interventions, particularly endoscopic enucleation, have led to new types of bladder ...